Morphine administration in horses anaesthetized for upper respiratory tract surgery



      To determine the effect of morphine administration on commonly monitored cardio-respiratory variables and recovery quality in horses undergoing anaesthesia and surgery.

      Study design

      Prospective, randomized clinical study.


      Thirty-eight thoroughbred horses, 32 geldings and six mares, 3–13 years old, weighing 411–600 kg.

      Materials and methods

      A standard anaesthetic technique was used. Twenty minutes after induction of anaesthesia horses received 0.1 mg kg−1 (0.1 m) or 0.2 mg kg−1 (0.2 m) morphine by intravenous injection. A control group did not receive morphine. Heart rate, respiratory rate (fr), mean arterial pressure (MAP) and blood gases were measured before morphine administration and every 10 minutes thereafter. Horses were positioned for 35 minutes in right lateral recumbency for tension palatoplasty by cautery and were then moved into dorsal recumbency for additional intraluminal surgery comprising one or more of aryepiglottic fold resection, sub-epiglottal mucosal resection, ventriculectomy and cordectomy. A subjective recovery score from 0 (worst) to 5 (best) was assigned by a single observer who was unaware of treatment group. Two-way repeated measures anova, one-way anova, Kruskal–Wallis test, Mann–Whitney test, Pearson and Spearman correlation coefficients, and chi-squared tests were used to analyse the data where appropriate.


      Arterial partial pressure of oxygen (PaO2) decreased significantly over time and was significantly lower in horses that received morphine. One horse in the control group and two horses in each of the morphine groups had a PaO2 <13 kPa. No other significant cardiopulmonary effects were detected. Recovery scores [median (range)] were higher in morphine recipients: 4 (2–5) in 0.1 m, 4 (3–5) in 0.2 m compared with 3 (2–4) in the control group.

      Conclusions and Clinical relevance

      The lower PaO2 in morphine recipients did not appear to be of clinical significance in healthy horses because the number of horses with a low PaO2 was similar between groups. The quality of recovery was significantly better in morphine recipients. These results indicate that morphine may be considered for use in clinical cases although further work is required to assess the analgesic properties of the drug in this species.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Veterinary Anaesthesia and Analgesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bennett RC
        • Steffey EP
        • Kollias-Baker C
        • et al.
        Influence of morphine sulphate on the halothane sparing effect of xylazine hydrochloride in horses.
        Am J Vet Res. 2004; 65: 519-526
        • Clark L
        • Clutton RE
        • Blissitt KJ
        • et al.
        Effects of perioperative morphine administration during halothane anaesthesia in horses.
        Vet Anaesth Analg. 2005; 32: 10-15
        • Combie J
        • Shults T
        • Nugent EC
        • et al.
        Pharmacology of narcotic analgesics in the horse: selective blockade of narcotic-induced locomotor activity.
        Am J Vet Res. 1981; 42: 716-721
        • Grandy JL
        • Steffey EP
        • Hodgson DS
        • et al.
        Arterial hypotension and the development of postanaesthetic myopathy in halothane-anaesthetised horses.
        Am J Vet Res. 1987; 48: 192-197
        • Hall LW
        Disturbances of cardiopulmonary function in anaesthetised horses.
        Equine Vet J. 1971; 3: 95-98
        • Hall LW
        • Gillespie JR
        • Tyler WS
        Alveolar-arterial oxygen tension differences in anaesthetised horses.
        Brit J Anaesth. 1968; 40: 560-567
        • Hellyer PW
        • Bai L
        • Supon J
        • et al.
        Comparison of opioid and alpha-2 adrenergic receptor binding in horse and dog brain using radioligand autoradiography.
        Vet Anaesth Analg. 2003; 30: 172-182
        • Johnson CB
        • Taylor PM
        Effects of alfentanil on the equine electroencephalogram during anaesthesia with halothane in oxygen.
        Res Vet Sci. 1997; 62: 159-163
        • Johnston GM
        • Eastment JK
        • Wood JLN
        • et al.
        The confidential enquiry into perioperative equine fatalities (CEPEF): mortality results of Phases 1 and 2.
        Vet Anaesth Analg. 2002; 29: 159-170
        • Kalpravidh M
        • Lumb WV
        • Wright M
        • et al.
        Effects of butorphanol, flunixin, levorphanol, morphine and xylazine in ponies.
        Am J Vet Res. 1984; 45: 211-217
        • Kamerling S
        • Wood T
        • Weckman TJ
        • et al.
        Narcotic analgesics, their detection and pain measurement in the horse: a review.
        Equine Vet J. 1989; 21: 4-12
        • Klein LV
        • Baetjer C
        Preliminary report: xylazine and morphine sedation in horses.
        Vet Anaesth. 1974; 1: 2-6
        • Mircica E
        • Clutton RE
        • Kyles KW
        • et al.
        Problems associated with perioperative morphine in horses: a retrospective case analysis.
        Vet Anaesth Analg. 2003; 30: 147-155
        • Muir WM
        • Skarda RT
        • Sheehan WC
        Cardiopulmonary effects of narcotic agonists and a partial agonist in horses.
        Am J Vet Res. 1978; 39: 1632-1635
        • Muir WM
        • Skarda RT
        • Sheehan WC
        Hemodynamic and respiratory effects of xylazine-morphine sulfate in horses.
        Am J Vet Res. 1979; 40: 1417-1420
        • Nolan AM
        • Chambers JP
        • Hale GJ
        The cardiorespiratory effects of morphine and butorphanol in horses anaesthetised under clinical conditions.
        J Vet Anaesth. 1991; 18: 19-24
        • Pascoe PJ
        • Steffey EP
        • Black WD
        • et al.
        Evaluation of the effect of alfentanil on the minimum alveolar concentration of halothane in horses.
        Am J Vet Res. 1993; 54: 1327-1332
        • Senior JM
        • Pinchbeck GL
        • Dugdale AHA
        • et al.
        Retrospective study of the risk factors and prevalence of colic in horses after orthopaedic surgery.
        Vet Rec. 2004; 55: 321-325
        • Steffey EP
        • Howland D
        Cardiovascular effects of halothane in the horse.
        Am J Vet Res. 1978; 39: 611-615
        • Steffey EP
        • Baggot JD
        • Eisele JH
        • et al.
        Morphine-isoflurane interaction in dogs, swine and Rhesus monkeys.
        J Vet Pharmacol Ther. 1994; 17: 202-210
        • Steffey EP
        • Eisele JH
        • Baggot JD
        Interactions of morphine and isoflurane in horses.
        Am J Vet Res. 2003; 64: 166-175
        • Taylor PM
        Effect of postoperative pethidine on the anaesthetic recovery period in the horse.
        Equine Vet J. 1986; 18: 70-72
        • Taylor PM
        • Bennett RC
        • Brearley JC
        • et al.
        Comparison of detomidine and romifidine as premedicants before ketamine and halothane anaesthesia in horses undergoing elective surgery.
        Am J Vet Res. 2001; 62: 359-363
        • Young SS
        • Taylor PM
        Factors influencing the outcome of equine anaesthesia: a review of 1,314 cases.
        Equine Vet J. 1993; 25: 147-151

      Uncited Reference

        • Hall LW
        • Taylor PM
        Clinical trial of xylazine with ketamine in equine anaesthesia.
        Vet Rec. 1981; 108: 489-493